Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898508 · ClinicalTrials.gov registry record
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 563
- Enrollment target
NCT00898508 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 563 participants.
The verdict
NCT00898508 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 563 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of blood and tumor tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is studying blood and tumor tissue samples in women with invasive breast cancer, ductal carcinoma in situ, lobular carcinoma in situ, or benign breast disease.
Interventions
- GENETIC gene expression analysis
- GENETIC mutation analysis
- GENETIC reverse transcriptase-polymerase chain reaction
- GENETIC proteomic profiling
- OTHER fluorescent antibody technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 563 participants |
| Start Date | 2005-08 |
| Est. Completion | 2019-06-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00898508
The ClinicalTrials.gov registry entry for NCT00898508 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 563 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00898508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00898508 about?
NCT00898508 is a clinical study titled "Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease". RATIONALE: Collecting and storing samples of blood and tumor tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is studying blood and tumor tissue samples in women with invasive breast cancer, ductal carcinoma in situ,...
What is the current status of trial NCT00898508?
This trial is currently completed. The enrollment target is 563 participants. The study started on 2005-08. Estimated completion is 2019-06-06.
What interventions are being tested in trial NCT00898508?
The interventions under investigation include: gene expression analysis (GENETIC), mutation analysis (GENETIC), reverse transcriptase-polymerase chain reaction (GENETIC), proteomic profiling (GENETIC), fluorescent antibody technique (OTHER).
Who is sponsoring clinical trial NCT00898508?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.